[1] |
Pentheroudakis G, Pavlidis N. Cancer and pregnancy:Poena magna, not anymore[J]. Eur J Cancer, 2006, 42:126-140.
|
[2] |
Pentheroudakis G. Cancer and pregnancy[J]. Ann Oncol, 2008, 19:38-39.
|
[3] |
Insinga RP, Glass AG, Rush BB. Diagnosis and outcomes in cervical cancer screening: A population-based study[J]. Am J Obstet Gynecol, 2004, 191:105-113.
|
[4] |
Germann N, Haie-Meder C, Morice P, et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer[J]. Ann Oncol, 2005, 16:397-402.
|
[5] |
Morice P, Uzan C, Gouy S, et al. Gynaecological cancer in pregnancy[J]. Lancet, 2012, 379:558-569.
|
[6] |
French Working Group on Gynecollogical Cancers in Pregnancy. French recommendations on the management of invasive cervical cancer during pregnancy[J]. In J Gynecol Cancer, 2009, 19:1638-1641.
|
[7] |
Amant F, Van Calsteren K, HalaskaMJ, et al. Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting[J]. Int J Gynecol Cancer, 2009, 19(suppl 1):S1-12.
|
[8] |
Cardonick E, Dougherty R, Grana G, et al. Breast cancer during pregnancy: Maternal and fetal outcomes[J]. Cancer J, 2010, 16:76-82.
|
[9] |
Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy[J]. Lancet, 2012, 379:570-579.
|
[10] |
Backes CH, Moorehead PA, Nelin LD. Cancer in pregnancy: Fetal and neonatal outcomes[J]. Clin Obstet Gynecol, 2011, 54:574-590.
|
[11] |
Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy[J]. Lance Oncol, 2004, 5:283-291.
|
[12] |
Mir O, Berveiller P, Goffinet F, et al. Taxanes for breast cancer during pregnancy: A systematic review[J]. Ann Oncol, 2010: 21:425-426.
|